PSYCHIATRISCHE PRAXIS, an esteemed journal published by GEORG THIEME VERLAG KG, serves as a vital resource in the field of psychiatry and mental health. Established in 1974, this German journal offers a compelling mix of original research, clinical insights, and theoretical discussions, contributing to the advancement of knowledge up to its historical convergence slated for 2024. With a distinguished Scopus ranking of #250 out of 567 in the Psychiatry and Mental Health category, and a 2023 Category Quartile of Q3, it stands as a significant platform for researchers and professionals. The journal does not currently offer Open Access options; however, its reputation and impact within the community place it as a valuable asset for those dedicated to understanding and improving mental health practices. PSYCHIATRISCHE PRAXIS engages its readership with innovative studies and authoritative viewpoints, making it an essential tool for scholars, practitioners, and students aiming to enrich their insight into psychiatric care and research.

Psychiatry and Clinical Psychopharmacology, an open-access journal published by AVES since 2017, is dedicated to advancing the fields of psychiatric medicine and psychopharmacology. With an ISSN of 2475-0573 and an E-ISSN of 2475-0581, this journal aims to provide a platform for disseminating innovative research and clinical findings relevant to mental health professionals and researchers. Although it currently holds a Q3 ranking in Pharmacology (medical) and a Q4 ranking in Psychiatry and Mental Health according to the 2023 category quartiles, the journal has established itself as a significant contributor to evolving discussions in these critical fields. Based in the United Kingdom, the journal encompasses diverse topics, ranging from pharmacological treatments to novel therapeutic approaches in psychiatry, thereby appealing to a broad audience of clinicians, scientists, and students. The open-access model ensures that all research is readily available, fostering an environment of collaboration and knowledge-sharing as the journal converges until 2024 to encompass the latest advancements in both pharmacology and clinical psychopharmacology.

The Indian Journal of Psychological Medicine, published by SAGE Publications Inc, stands as a key resource within the fields of Clinical Psychology and Psychiatry, recognized for its commitment to advancing the understanding and practice of psychological medicine. With an E-ISSN of 0975-1564 and an ISSN of 0253-7176, this journal operates under an Open Access model since 2016, ensuring that cutting-edge research is accessible to all. Based in the United Kingdom, it has achieved notable impact in its category, landing in the Q2 quartile for both Clinical Psychology and Psychiatry and Mental Health as of 2023. With Scopus ranks reflecting its significance—#84 out of 311 in Clinical Psychology and #204 out of 567 in Psychiatry and Mental Health—the journal provides a platform for impactful research and clinical insights, contributing towards better mental health practices globally. Researchers, professionals, and students alike will find the journal’s diverse scope and commitment to quality scholarship invaluable in their pursuit of knowledge.

Current Psychiatry Research and Reviews is an innovative open access journal dedicated to the dynamic field of psychiatry and mental health. Published by Bentham Science Publishers Ltd, this journal provides a platform for researchers and practitioners to disseminate pivotal findings, reviews, and advancements in psychiatric research. While the journal currently holds a Q4 status in the Psychiatry and Mental Health category, it seeks to elevate standards with interdisciplinary contributions aimed at improving patient outcomes and treatment methodologies. With a publication window spanning from 2019 to 2024, the journal aims to enhance global discussions in mental health sciences, encouraging submissions that explore evidence-based practices, innovative therapeutic techniques, and the epidemiology of mental health disorders. The journal's address in the Netherlands positions it strategically within Europe’s vibrant research community, making it an essential resource for researchers, professionals, and students alike who are invested in the evolution of psychiatric science.

Indian Journal of Psychiatry (ISSN: 0019-5545, E-ISSN: 1998-3794) is a premier, peer-reviewed academic journal published by WOLTERS KLUWER MEDKNOW PUBLICATIONS. As a leading publication in the field of psychiatry and mental health since its establishment in 1970, the journal has significantly contributed to the advancement of psychiatric research and clinical practice in India and globally. With an impact factor reflecting its robust academic reputation, the journal is categorized under the Q3 quartile in its field for 2023 and ranks #228 out of 567 in the Scopus rankings. This Open Access journal has been providing cutting-edge research insights since 2007, ensuring that access to vital findings and innovative methodologies is available to a wide readership without restrictions. The Indian Journal of Psychiatry is dedicated to the dissemination of quality research, clinical studies, and reviews, aiming to enhance understanding and treatment of mental health disorders. It serves as an essential resource for researchers, practitioners, and students striving to improve mental health outcomes in diverse populations.

BJPsych Open, published by Cambridge University Press, is a leading open access journal dedicated to the field of psychiatry and mental health. Since its inception in 2015, the journal has provided a platform for disseminating cutting-edge research and evidence-based practices, making significant contributions to the academic community. With an impressive impact factor and currently ranking in the top Q1 quartile of its field, BJPsych Open is recognized for its rigor and relevance, ranking 138 out of 567 journals in psychiatry and mental health according to Scopus, placing it in the 75th percentile. The journal's commitment to open access enhances visibility and accessibility, ensuring that vital research is available to a global audience. Researchers, professionals, and students alike will find valuable insights into contemporary mental health challenges and innovative treatment approaches, making BJPsych Open an essential resource for advancing mental health scholarship.

NEUROPSYCHIATRIE, published by SPRINGER WIEN, is a prestigious journal operating from Austria that focuses on advancing the fields of Clinical Psychology and Psychiatry. With an ISSN of 0948-6259 and an E-ISSN of 2194-1327, NEUROPSYCHIATRIE has garnered attention within the academic community, exemplified by its classification in the Q2 category for Clinical Psychology and Q3 for Psychiatry and Mental Health as of 2023. The journal provides a platform for the dissemination of innovative research findings and clinical insights, critical for professionals dedicated to addressing complex neuropsychiatric conditions. Researchers aspiring to explore the intricacies of mental health will find a wealth of knowledge, as evidenced by its Scopus rankings—115th in Clinical Psychology and 260th in Psychiatry and Mental Health—indicating its influential position. Covering a wide range of topics from neurobiology to psychotherapeutic interventions, NEUROPSYCHIATRIE acts as a vital resource, making significant contributions to enhancing clinical practices and fostering interdisciplinary collaborations in mental health.

The BULLETIN OF THE MENNINGER CLINIC, an esteemed publication of GUILFORD PUBLICATIONS INC, has been a pivotal resource in the fields of Clinical Psychology and Psychiatry since its inception in 1945. With ISSN 0025-9284 and E-ISSN 1943-2828, this journal is recognized for its commitment to advancing knowledge and practices in mental health. Indexed in Scopus with respectable rankings across various categories, it stands in the Q3 quartile for both Clinical Psychology and Psychiatry and Mental Health, indicating its role as a significant contributor to academic discourse. Although it operates under a subscription model, the journal features a broad spectrum of peer-reviewed articles, case studies, and research findings that are essential for professionals, researchers, and students dedicated to understanding and improving mental health care. The BULLETIN OF THE MENNINGER CLINIC serves as a vital platform for interdisciplinary dialogue, fostering innovative approaches and methodologies that shape the future of mental health treatment and research.

Mental Illness is a pioneering open-access journal dedicated to advancing the field of psychiatry and mental health since its inception in 2009. Published by HINDAWI LTD, this journal serves as a vital platform for researchers, clinicians, and students worldwide, enabling the dissemination of innovative studies that explore diverse aspects of mental health. With an ISSN of 2036-7457 and an E-ISSN of 2036-7465, it has made a significant impact, earning a Q3 category ranking in the Psychiatry and Mental Health field and ranking #441 in Scopus, reflecting its commitment to quality scholarly work. The journal encourages the submission of original research, reviews, and case studies, fostering a collaborative environment for knowledge exchange and scientific advancement. Additionally, being an open-access journal ensures that its valuable findings are accessible to a wide audience, further promoting research and understanding of mental illness across the globe. Situated in the heart of the United Kingdom, at Adam House, 3rd Flr, 1 Fitzroy Sq, London W1T 5HF, the journal aspires to shape the future of mental health research and treatment.

Psychiatria Polska is a distinguished journal published by WYDAWNICZY POLSKIEGO TOWARZYSTWA, focused on advancing the field of psychiatry and mental health. Established in 1967, this journal has become a vital resource for researchers, clinicians, and students, contributing to the understanding of psychiatric disorders and their treatments. With an ISSN of 0033-2674, it features a diverse range of studies, case reports, and reviews, making it an essential platform for sharing innovative findings within the psychiatric community. Although currently categorized in the Q3 quartile for both Medicine (miscellaneous) and Psychiatry and Mental Health in 2023, its increasing impact is evidenced by its Scopus ranking of #345 out of 567 in its category, placing it in the 39th percentile. Located in Cracow, Poland, Psychiatria Polska continues to foster international collaboration and knowledge exchange, despite being non-open access, ensuring that its high-quality content reaches a wide audience. This journal is dedicated to enhancing the dialogue on mental health, making it an indispensable resource for those committed to improving psychiatric practice and research.